Interpretation Response #99-0192 ([Bio-Safe America, Inc.] [Ms. Samantha Burdick])
Below is the interpretation response detail and a list of regulations sections applicable to this response.
Interpretation Response Details
Response Publish Date:
Company Name: Bio-Safe America, Inc.
Individual Name: Ms. Samantha Burdick
Location State: FL Country: US
View the Interpretation Document
Response text:
December 16, 1999
Ms. Samantha Burdick Ref. No. 99-0192
Office Manager
Bio-Safe America, Inc.
4301 32nd Street West, Suite C-16
Bradenton, Florida 34205
Dear Ms. Burdick:
This is in response to your letter dated July 12, 1999, requesting clarification of the packaging exceptions in 49 CFR 173.134(b)(3) for “Regulated Medical Waste, 6.2, UN 3291, PG II” in the Hazardous Materials Regulations (HMR; 49 CFR Parts 171-180).
Your understanding of the exceptions in § 173.134(b)(3) is correct. As provided by § 173.134(b)(3), a regulated medical waste that is transported by a private or contract carrier is excepted from: (1) the “INFECTIOUS SUBSTANCE” label, if the-outer packaging is marked with a “BIOHAZARD” marking conforming to 29 CFR 1910.1030, and (2) for other than a waste culture or stock of an infectious substance, the specific packaging requirements in § 173.197, if packaged in a rigid, non-bulk package conforming to §§ 173.24 and 173.24a, and 29 CFR 1910.1030.
1 hope this satisfies your request.
Sincerely,
Delmer F. Billings
Chief, Standards Development
Office of Hazardous Materials Standards
173.134
Regulation Sections
| Section | Subject |
|---|---|
| 173.134 | Class 6, Division 6.2-Definitions and exceptions |